Roth receives DARPA award for metabolic-hibernation research

Hutch News

Roth receives DARPA award for metabolic-hibernation research

Sept. 1, 2007

The Basic Sciences Division's Dr. Mark Roth received a Defense Advanced Research Projects Agency Award for Excellence during DARPA Tech 2007 last week in Anaheim, Calif.

DARPA Director Dr. Anthony Tether presented the Award for Significant Technical Achievement to Roth for his leadership and scientific expertise to the DARPA Surviving Blood Loss program. Roth and his team successfully demonstrated a hydrogen sulfide therapy involving the reversible reduction of a mammal's metabolic activity without long-term side effects. The results of this effort have led to technology that could dramatically improve the survival rate of wounded fighters and provide revolutionary improvements in the prevention and control of other medical complications on the battlefield. DARPA is a major funder of Roth's research.

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.